权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The role of dendrin in glomerular disease progression

树突蛋白在肾小球疾病进展中的作用

基本信息

批准号：
9344584
负责人：
Kirk N Campbell
金额：
$ 38.14万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-10 至 2020-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9344584
关键词：
Address Affect Apoptotic Architecture Binding Biological Cell Nucleus Cell Survival Cells Clinical Cytoplasm Data Deposition Development Disease Disease Progression End stage renal failure Fibronectins Focal Segmental Glomerulosclerosis Gene Deletion Genetic Transcription Goals Human In Vitro Injury Kidney Knowledge Mediating Mediator of activation protein Modeling Molecular Mus Nuclear Nuclear Translocation Outcome Pathogenesis Pathogenicity Pathway interactions Pharmaceutical Preparations Phosphorylation Physiological Process Protein Inhibition Protein Isoforms Proteins Proteomics Renal glomerular disease Research Role Signal Pathway Signal Transduction Signaling Molecule Steroid Resistance System Technology Testing Therapeutic Therapeutic Agents Therapeutic Intervention Transcription Factor AP-1 Transgenic Mice Transgenic Organisms Work base cell injury cost dendrin genetic variant glomerulosclerosis improved in vivo inhibitor/antagonist innovation mesangial cell mouse model mutant new therapeutic target novel novel therapeutic intervention novel therapeutics podocyte public health relevance therapeutic target

项目摘要

DESCRIPTION (provided by applicant): A critical barrier to the identification of appropriate therapeutic targets to treat glomerular disease is the limited understanding of signaling cascades that regulate podocyte injury and renal survival. Our long term goal is to enhance the pipeline of putative therapeutic targets available to tackle human glomerular disease by elucidating the details and functional significance of key signaling pathways that regulate podocyte injury and survival. Our preliminary data have identified dendrin as a key pro injury signaling molecule that promotes podocyte depletion and is involved in podocyte mesangial cell crosstalk. We have identified human dendrin gene variants that segregate with familial steroid resistant focal segmental glomerulosclerosis (FSGS) and identified the pro survival Hippo pathway effector Yes associated protein (YAP) as an inhibitor of dendrin function. The overall objective of this application is to define the role of dendrin as a key mediator of pathogenic podocyte mesangial cell crosstalk and subsequent glomerular disease progression.Our central hypothesis is that dendrin is regulated in a phosphorylation dependent manner by YAP, where disease associated dendrin mutants may induce podocyte injury though decreased YAP inhibition. Dendrin regulated soluble factors from podocytes promote mesangial cell fibronectin secretion, leading to mesangial matrix expansion and glomerular disease progression. The rationale for the proposed research is that defining how dendrin function is inhibited by YAP and characterizing its role in glomerular disease progression will advance understanding of glomerular disease progression as well as the quest for novel therapeutic targets available for clinical use. Our hypothesis will be tested by pursuing two specific aims: Aim 1 will explore the inhibition of wild type and FSGS associated dendrin mutants by YAP. We will define the molecular interaction between phosphorylated YAP and the dendrin isoforms and characterize the consequences of binding in the context of cell survival and dendrin subcellular localization and function. We will also test in vivo whether transgenic expression of YAP in podocytes slows murine glomerular disease progression by inhibiting dendrin function. In Aim 2 we will define the role of dendrin in pathogenic podocyte mesangial cell crosstalk using our novel established in vitro cell systems as well as an inducible transgenic mouse model of crosstalk. Our innovative approach utilizes state of the art proteomics technology to identify dendrin regulated soluble factors from podocytes that induce mesangial cell fibronectin secretion. These contributions are significant because they represent the first step in a continuum of research that is expected to advance understanding of glomerular disease progression and identify therapeutic targets and strategies to improve clinical outcomes.